Stewart Brand’s “Maintenance: Of Everything, Part One” (Stripe, 308 pages, $40) begins with a drama that belies the book’s seemingly humdrum topic. The author recounts the stories of three contestants ...

This is part 2 of an experimental series where I make a song from start to finish, while recording the process, and say a few words about the things I use. I want you listeners to suggest what should ...

I made a terrible mistake. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Splitting a story into two films always feels more like a studio ...

BATTLE CREEK, Mich., Nov. 10, 2025 /PRNewswire/ -- Did you know Kellogg's® Froot Loops® has been name-dropped in more than 1,000 hip-hop tracks across generations1? To celebrate hip-hop's creative ...

All lanes of the Capital Beltway are now open after a crash shut down the Inner and Outer loops between Maryland Route 210 and St. Barnabas Road earlier Friday morning. One person is dead and two ...

Looking for a fun activity to do this fall? One of the country's best corn mazes is in Massachusetts, according to USA TODAY's 10BEST Readers' Choice Awards. The annual rankings highlight the best in ...

Capital One is settling a class action lawsuit brought against the bank holding company for allegedly freezing its savings account rates for several years, effectively barring customers from bagging ...

(NEXSTAR) — You have just a few days left to claim your portion of a massive settlement in a class action lawsuit brought against Capital One. Capital One was previously sued over its savings accounts ...

MOUNT PLEASANT, S.C. (WCBD) – Boone Hall is preparing to kick off its annual corn maze and pumpkin patch on Friday, September 26. Officials gave News 2 a preview of what’s in store for this year’s ...

The first part of the WTO’s treaty banning harmful fisheries subsidies, known as Fish One, entered into force Sept. 15 after more than two decades of negotiation and three years of ratification. It ...

Maze Therapeutics, Inc. (NASDAQ:MAZE) on Thursday shared clinical results from the Phase 1 healthy volunteer study of MZE782, an oral small molecule targeting the solute transporter, SLC6A19. MZE782 ...